{"version":"1.2.0","chapters":[{"startTime":0,"title":"Begr\u00fc\u00dfung"},{"startTime":232.203,"title":"Peptidhormone: Insulin","img":"https:\/\/wsr.jointech.dev\/wp-content\/uploads\/2024\/03\/Insulin_Monomer.png"},{"startTime":571.864,"title":"Das Insulin Dimer","img":"https:\/\/wsr.jointech.dev\/wp-content\/uploads\/2024\/03\/Insulin_Dimer.png"},{"startTime":633.919,"title":"Das Insulin Hexamer","img":"https:\/\/wsr.jointech.dev\/wp-content\/uploads\/2024\/03\/Insulin_Hexamer.png"},{"startTime":747.756,"title":"Bauchspeicheldr\u00fcse"},{"startTime":842.696,"title":"Insulinrezeptoren"},{"startTime":933.667,"title":"Aufnahme der Glucose"},{"startTime":1122.479,"title":"Insulin Aussch\u00fcttung"},{"startTime":1342.331,"title":"Weitere Wirkungen des Insulins"},{"startTime":1410.008,"title":"Einf\u00fchrung Diabetestherapie"},{"startTime":1447.909,"title":"Therapie mit Insulin und Insulinanaloga"},{"startTime":1657.707,"title":"Entdeckung der Antidiabetika"},{"startTime":1747.448,"title":"Sulfacarbamid"},{"startTime":1910.902,"title":"Tolbutamid"},{"startTime":2030.565,"title":"Wirkung der Sulfonylharnstoffe"},{"startTime":2185.731,"title":"Sulfonylharnstoffe der 2. Generation: Glibenclamid"},{"startTime":2335.097,"title":"Hypoglyk\u00e4mie durch \u00dcberdosierung von Glibenclamid"},{"startTime":2399.508,"title":"Entdeckung der Benzamidobindestelle"},{"startTime":2520.645,"title":"Glinide"},{"startTime":2587.207,"title":"Nateglinid"},{"startTime":2656.035,"title":"Chemische Eigenschaften von Sulfonylharnstoffen"},{"startTime":2748.177,"title":"Definition Scaffold Hopping"},{"startTime":2982.353,"title":"Repaglinid"},{"startTime":3043.573,"title":"Metformin"},{"startTime":3245.975,"title":"Glitazone"},{"startTime":3476.244,"title":"Thiazolidindion"},{"startTime":3549.723,"title":"GLP-Modulatoren"},{"startTime":3882.338,"title":"Inkretin Hormonanaloga"},{"startTime":3949.089,"title":"Liraglutid"},{"startTime":3979.031,"title":"Weitere Wirkungen der Inkretinmimetika"},{"startTime":4059.746,"title":"Inaktivierung des Enkretinabbau"},{"startTime":4163.238,"title":"Semaglutid"},{"startTime":4321.411,"title":"Gliptine als DPP Hemmer"},{"startTime":4645.342,"title":"Gliflozine als SGLT-2 Inhibitoren"},{"startTime":4842.405,"title":"Entdeckung der SGLT Hemmer"},{"startTime":5060.196,"title":"Struktur der Gliflozine"},{"startTime":5169.543,"title":"alpha-Glucosidase Hemmer"},{"startTime":5256.656,"title":"Acarbose"},{"startTime":5587.698,"title":"Verabschiedung und Bitte um Feedback"}]}